At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 327 enrolled
Drug / intervention
nepafenacdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Nepafenac Eye Drops on Intraocular Pressure - a Randomized Prospective Study
In Brief
A Phase 4 clinical trial evaluating nepafenac for Intraocular Pressure. Completed, enrolled 327 participants across 1 site.
Detailed Summary
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntraocular Pressure
CountriesIndia
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
Primary CompletionFeb 2013
Study CompletionApr 2013
First PostedNov 2013
TodayJul 2026
First PostedNov 27, 2013
Enrollment StartDec 1, 2012
Primary CompletionFeb 1, 2013
Study CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.6 years ago
Interventions
nepafenacdrug